Scheerlinck Jean-Pierre Y, Gloster Simone, Gamvrellis Anita, Mottram Patricia L, Plebanski Magdalena
Centre for Animal Biotechnology, The University of Melbourne, Vic. 3010, Australia.
Vaccine. 2006 Feb 20;24(8):1124-31. doi: 10.1016/j.vaccine.2005.09.009. Epub 2005 Sep 19.
Although a number of adjuvants are currently approved for use in veterinary species, only alum has been widely used in humans. While it induces strong antibody responses, cell mediated responses are often low and inflammatory reactions at the site of injection are common. We investigated the immunological properties of a novel nano-bead adjuvant in a sheep large-animal model. In contrast to alum, antigen covalently coupled to nano-beads induced substantial cell mediated responses along with moderate humoral responses. No adverse reactions were seen at the site of immunisation in the sheep. Thus, nano-bead adjuvants in veterinary species may be useful for the induction of immunity to viral pathogens, where a cell mediated response is required. These findings also highlight the potential usefulness of nano-bead vaccines for intracellular pathogens in humans.
虽然目前有多种佐剂被批准用于兽医领域,但只有明矾在人类中得到广泛应用。虽然它能诱导强烈的抗体反应,但细胞介导的反应通常较低,且注射部位的炎症反应很常见。我们在绵羊大型动物模型中研究了一种新型纳米珠佐剂的免疫学特性。与明矾不同,与纳米珠共价偶联的抗原诱导了大量的细胞介导反应以及适度的体液反应。在绵羊的免疫部位未观察到不良反应。因此,兽医领域的纳米珠佐剂可能有助于诱导对病毒病原体的免疫,而这需要细胞介导的反应。这些发现也凸显了纳米珠疫苗对人类细胞内病原体的潜在效用。